During ASMS 2024, which will take place June 2–6, 2024 in Anaheim, California, many scientists are set to present research on the latest advances in mass spectrometry. Recently, LCGC International sat down with Uri Keshet of the University of California, Davis to discuss his presentation, "Metabolomics of 13,700 human plasma samples for the TEDDY cohort: A Big Data Challenge and Opportunity for Mass Spectrometry."
Uri Keshet is the Technical Director at the UC Davis Genome Center - Metabolomics in the University of California, Davis in Davis, California (1). In 2012, he earned his Bachelors in Chemistry, Tel Aviv University, Tel Aviv, Israel, and in 2018, he received a PhD in chemistry from Tel Aviv University as well. His research interests include analytical chemistry, chromatographic separation technologies, development of novel instrumentation, and the development of new methods for MS analysis techniques.
In this interview, Keshet answers the following questions:
To learn more about presentations at ASMS 2024, check out our interviews with Elizabeth Neumann of the University of California, Davis and Nick Riley of the University of Washington.
(1) Uri Keshet. Fiehn Lab 2024. https://fiehnlab.ucdavis.edu/component/contact/contact/11-members/15-cheminformatics-and-compound-id/54 (accessed 2024-5-31)
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.